NRBO
Price:
$2.36
Market Cap:
$3.70M
NeuroBo Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm committed to advancing treatments for a spectrum of challenging conditions, encompassing neurodegenerative disorders, infectious diseases, and cardiometabolic ailments. The company's diverse pipeline includes several investigational therapies: ANA001, an orally administered formulation of niclosamide, is currently progressing through Phase 2/3 clinical trials to treat individuals with moderate coronavirus disease (COVID-19). NB-01 is being developed to alleviate the discomfort associated with painful diabetic neuropathy. NB-02 targets the management of cognitive decline symptoms and seeks to alter the course of...[Read more]
Industry
Biotechnology
IPO Date
2016-08-05
Stock Exchange
NASDAQ
Ticker
NRBO
According to NeuroBo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.55. This represents a change of -55.65% compared to the average of -1.24 of the last 4 quarters.
The mean historical PE Ratio of NeuroBo Pharmaceuticals, Inc. over the last ten years is -0.28. The current -0.55 PE Ratio has changed 19.36% with respect to the historical average. Over the past ten years (40 quarters), NRBO's PE Ratio was at its highest in in the June 2017 quarter at -0.00. The PE Ratio was at its lowest in in the June 2023 quarter at -4.22.
Average
-0.28
Median
-0.01
Minimum
-1.15
Maximum
-0.00
Discovering the peaks and valleys of NeuroBo Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.67%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -50.06%
Minimum Annual PE Ratio = -1.15
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.15 | 100.90% |
| 2024 | -0.57 | -44.56% |
| 2023 | -1.03 | 1.67% |
| 2022 | -0.06 | 264.64% |
| 2021 | -0.02 | 177.27% |
| 2020 | -0.01 | 122.95% |
| 2019 | -0.00 | 947.79% |
| 2018 | -0.00 | 88.89% |
| 2017 | -0.00 | -50.06% |
| 2016 | -0.00 | -11.91% |
The current PE Ratio of NeuroBo Pharmaceuticals, Inc. (NRBO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.91
5-year avg
-0.56
10-year avg
-0.28
NeuroBo Pharmaceuticals, Inc.’s PE Ratio is less than MEI Pharma, Inc. (-0.11), less than Elevation Oncology, Inc. (-0.47), greater than Traws Pharma, Inc. (-0.69), less than PHAXIAM Therapeutics S.A. (-0.02), less than Kineta, Inc. (-0.40), greater than Pieris Pharmaceuticals, Inc. (-2.82), greater than Dominari Holdings Inc. (-0.72), less than Nymox Pharmaceutical Corporation (-0.01), less than Imunon, Inc. (-0.36), less than COSCIENS Biopharma Inc. (-0.40),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.11 | $20.45M | |
| -0.47 | $21.63M | |
| -0.69 | $9.15M | |
| -0.02 | $19.86M | |
| -0.40 | $7.05M | |
| -2.82 | $17.96M | |
| -0.72 | $56.99M | |
| -0.01 | $28.36K | |
| -0.36 | $6.85M | |
| -0.40 | $8.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroBo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroBo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeuroBo Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeuroBo Pharmaceuticals, Inc. (NRBO)?
What is the highest PE Ratio for NeuroBo Pharmaceuticals, Inc. (NRBO)?
What is the 3-year average PE Ratio for NeuroBo Pharmaceuticals, Inc. (NRBO)?
What is the 5-year average PE Ratio for NeuroBo Pharmaceuticals, Inc. (NRBO)?
How does the current PE Ratio for NeuroBo Pharmaceuticals, Inc. (NRBO) compare to its historical average?